Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Patient perspectives on physician conflict of interest in industry-sponsored clinical trials for multiple sclerosis therapeutics.
Enhancing Neural Transmission in Multiple Sclerosis (4-Aminopyridine Therapy).
Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients.
n-3 PUFAs Reduce T-Helper 17 Differentiation by Decreasing Responsiveness to Interleukin-6 in Isolated Splenic Mouse CD4+ T Cells.
The human papillomavirus vaccination is not associated with risk of multiple sclerosis or other demyelinating diseases.
Vital role of specialist MS nurses recognised in proposed guideline.
Chronic inflammatory demyelinating polyradiculoneuropathy: update on clinical features, phenotypes and treatment options.
Coincidence of spinal tumor (astrocytoma) and non-specific encephalomyelitis.
Severe relapses under fingolimod treatment prescribed after natalizumab.
Frontiers in therapeutic development of allopregnanolone for Alzheimer's disease and other neurological disorders.
Targeting cells in motion: migrating toward improved therapies.
Oxidative stress and neurodegenerative disease.
Free radicals: properties, sources, targets, and their implication in various diseases.
Pain-related mood influences pain perception differently in fibromyalgia and multiple sclerosis.
Disease modification in multiple sclerosis: an update.
The Effect of Fingolimod on Conversion of Acute Gadolinium-Enhancing Lesions to Chronic T1 Hypointensities in Multiple Sclerosis.
Increased Plasma Interleukin-32 Expression in Patients with Neuromyelitis Optica.
5-HT2 RECEPTORS FACILITATE JC POLYOMAVIRUS ENTRY.
Multiple Sclerosis (MS) as a demyelinating disease: a review on neurosurgical approaches.
Early tolerability and safety of fingolimod in clinical practice.
Conventional and Advanced Imaging in Neuromyelitis Optica.
ENDOCANNABINOID SYSTEM: A multi-facet therapeutic target.
Predicting degree of myelination based on diffusion tensor imagining of canines with mucopolysaccharidosis type I.
Hepatocyte Growth Factor Limits Autoimmune Neuroinflammation via Glucocorticoid-Induced Leucine Zipper Expression in Dendritic Cells.
Vitamin D Therapy in Experimental Allergic Encephalomyelitis Could be Limited by Opposing Effects of Sphingosine 1-Phosphate and Gelsolin Dysregulation.

Pages